Hints and tips:
...The company, which forges joint ventures with local doctors who own their own dialysis centres, said it priced its IPO at $22 a share, raising $165m....
...American Renal Associates, a dialysis provider bought by Centerbridge in a leveraged deal, rose more than 20 per cent in its market debut on Thursday on the New York Stock Exchange....
...For Fresenius, already the world’s largest provider of dialysis products and services, the acquisition will increase its presence in Europe, particularly eastern Europe, where it provides dialysis treatment...
...A third come from kidney dialysis. Earnings before interest, tax, depreciation and amortisation are forecast to grow from €29m last year to €64m this year....
...Fresenius Medical Care, which provides kidney dialysis services to 10 per cent of patients worldwide, rose 2.3 per cent to €33.97 as fears about the impact of new US Medicare restrictions receded....
...Gambro, the Swedish dialysis group, and the world's second-biggest, posted an initial 1.9 per cent advance to SKr106 as the company gave the market a pleasant surprise in announcing a special SKr29 a share...
...Shares in Gambro were suspended from trading following a report that the Swedish medical care company could be on the verge of selling its main kidney dialysis operation in a $3bn deal....
International Edition